Stephen Doster

  • Vanderbilt University

    The academic startup guy: Larry Marnett, founding dean of Basic Sciences

    In the early 1960s, young Larry Marnett received his amateur radio license from the Federal Communications Commission. He put up an antenna outside his Kansas City, Kansas, home and began tapping away in Morse code. “It was just so cool to be ‘talking’ to someone in California or Canada,” Marnett… Read More

    Jun. 1, 2022

  • Vanderbilt University

    Discovery of mosquito survival tactics leaves room for new disease vector control tactics

    The appendages that protrude from a mosquito’s head hold the sensory systems that account for nearly all of its ability to detect and respond to a wide range of chemical signals that are critical for its reproduction and its survival. At the molecular level, these systems rely on genes that… Read More

    Jun. 1, 2022

  • Vanderbilt University

    Diabetes, cardiovascular drug targets

    Type 2 diabetes, which affects more than 30 million Americans, increases risk of cardiovascular disease. Nearly 70% of people with Type 2 diabetes die from heart disease or stroke.  Maureen Gannon, PhD, and colleagues investigated the role of the inflammatory lipid signaling molecule PGE2 — acting through… Read More

    May. 26, 2022

  • Vanderbilt University

    Study identifies first cellular “chaperone” for zinc, sheds light on worldwide public health problem of zinc deficiency

    We need zinc: one-tenth of the proteins in our cells require this metal for their normal functions in all aspects of cell metabolism. We acquire zinc by eating it — in foods or multivitamin supplements — but up to 30% of people in some parts of the world are at… Read More

    May. 19, 2022

  • Vanderbilt University

    Molecular ‘switch’ may illuminate stomach disorders

    An international team that included researchers from Vanderbilt University Medical Center has discovered a molecular switch that induces rapid proliferation of zymogen granule-secreting chief cells in the stomach to regenerate damaged tissue. The finding, which was reported earlier this month in the journal Cell Stem Cell, may be crucial… Read More

    May. 19, 2022

  • Vanderbilt University

    Study sheds light on the dark side of obesity

    Obesity is an inflammatory condition that can damage tissues throughout the body, resulting in increased risk for cardiovascular disease, insulin resistance, type 2 diabetes and possibly kidney disease. The agents of inflammation are immune cells called macrophages, which accumulate in fatty tissue, and which produce inflammatory chemicals called cytokines. But… Read More

    May. 17, 2022

  • Vanderbilt University

    Collaborative research yields new protein structure

    Structure of a caveolin-1 complex obtained using cryo-electron microscopy. A protomer, or a structural unit, is highlighted in magenta. The image was cropped to focus on panel A of Figure 1 of the paper, modified and published here in accordance to a CC BY-NC 4.0 license. Read More

    May. 16, 2022

  • Vanderbilt University

    Vanderbilt University honors emeritus and emerita faculty

    Vanderbilt University has honored 35 retiring faculty members for their years of service by bestowing upon them the title of emerita or emeritus faculty. They were recognized during Vanderbilt’s Commencement ceremony on May 13. A faculty member who has served the university with distinction over a period of years and… Read More

    May. 13, 2022

  • Vanderbilt University

    Resistance to COVID-19 drug detected in lab study

    The virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism. The results of the laboratory study led by researchers at Vanderbilt University Medical Center and published April 28 in the journal Science… Read More

    May. 12, 2022

  • Vanderbilt University

    Resistance to COVID-19 drug detected in lab study

    The virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism. The results of the laboratory study led by researchers at Vanderbilt University Medical Center and published April 28 in the journal Science… Read More

    May. 12, 2022